| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5B | $3.5B | $3.4B | $3.2B | $0.8B | $0.7B | $4.8B | $4.3B |
| Cost of Revenue | $0.9B | $1.0B | $1.0B | $1.0B | $0.2B | $0.2B | $0.3B | $0.3B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.4B | $0.4B | $0.4B | $0.3B | $0.2B | $0.2B | $0.3B | $0.3B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.8B | $0.9B | $0.5B | $0.2B | $0.2B | $0.2B | $0.1B |
| Net Income | $0.6B | $0.6B | $0.7B | $0.4B | $0.3B | $0.2B | $0.1B | $0.2B |
| EPS (Basic) | $2.53 | $2.12 | $2.36 | $1.28 | $-0.60 | $0.53 | $1.19 | $2.29 |
| EPS (Diluted) | $2.38 | $2.02 | $2.26 | $1.24 | $-0.60 | $0.48 | $1.05 | $2.04 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.5B | $4.5B | $4.5B | $4.2B | $5.1B | $3.0B | $8.3B | $6.9B |
| Current Assets | $1.4B | $1.4B | $1.3B | $0.9B | $1.2B | $1.0B | $3.7B | $2.8B |
| Cash & Equivalents | $1.0B | $1.0B | $0.9B | $0.6B | $0.8B | $0.7B | $3.1B | $2.1B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.0B | $0.5B | $0.5B | $0.6B | $1.2B | $0.5B | $1.0B | $0.9B |
| Stockholders' Equity | $-0.3B | $-0.1B | $-0.0B | $-0.4B | $-0.2B | $-1.2B | $2.9B | $2.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $0.9B | $0.9B | — | — | — | $0.9B | $1.0B |
| Investing Cash Flow | $-0.0B | $-0.1B | $-0.1B | — | — | — | $-0.3B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.0B | $0.1B | $0.0B | $0.1B | $0.1B |
| Financing Cash Flow | $-1.0B | $-0.8B | $-0.5B | — | — | — | $0.4B | $-0.3B |